Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

BioCorRx (BICX) Depreciation & Amortization (IS) (2016 - 2025)

Historic Depreciation & Amortization (IS) for BioCorRx (BICX) over the last 15 years, with Q3 2025 value amounting to $71986.0.

  • BioCorRx's Depreciation & Amortization (IS) rose 97217.75% to $71986.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $181810.0, marking a year-over-year increase of 57698.09%. This contributed to the annual value of $33145.0 for FY2024, which is 2363.85% up from last year.
  • BioCorRx's Depreciation & Amortization (IS) amounted to $71986.0 in Q3 2025, which was up 97217.75% from $71977.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Depreciation & Amortization (IS) ranged from a high of $71986.0 in Q3 2025 and a low of $6665.0 during Q1 2023
  • Over the past 5 years, BioCorRx's median Depreciation & Amortization (IS) value was $6863.0 (recorded in 2021), while the average stood at $16870.4.
  • In the last 5 years, BioCorRx's Depreciation & Amortization (IS) plummeted by 6524.71% in 2021 and then skyrocketed by 97217.75% in 2025.
  • Over the past 5 years, BioCorRx's Depreciation & Amortization (IS) (Quarter) stood at $6863.0 in 2021, then dropped by 0.01% to $6862.0 in 2022, then decreased by 2.14% to $6715.0 in 2023, then soared by 93.66% to $13004.0 in 2024, then soared by 453.57% to $71986.0 in 2025.
  • Its last three reported values are $71986.0 in Q3 2025, $71977.0 for Q2 2025, and $24843.0 during Q1 2025.